Astellas Pharma Inc. (TYO: 4503)
Japan
· Delayed Price · Currency is JPY
1,670.50
+3.00 (0.18%)
Nov 15, 2024, 3:45 PM JST
Astellas Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | 61,833 | 24,969 | 132,361 | 156,886 | 145,324 | 245,350 | Upgrade
|
Depreciation & Amortization | 195,912 | 157,840 | 105,738 | 79,684 | 72,652 | 66,396 | Upgrade
|
Loss (Gain) From Sale of Assets | 66,288 | 78,931 | 84,499 | 74,850 | 100,348 | 13,796 | Upgrade
|
Other Operating Activities | -67,761 | -37,563 | -68,811 | -43,293 | -27,144 | -49,352 | Upgrade
|
Change in Accounts Receivable | -93,809 | -55,948 | -4,849 | -8,001 | 22,161 | -16,391 | Upgrade
|
Change in Inventory | -47,597 | -60,036 | -7,086 | 24,058 | -2,318 | -6,038 | Upgrade
|
Change in Accounts Payable | 38,632 | 29,466 | -12,274 | -10,101 | -51,569 | -21,363 | Upgrade
|
Change in Other Net Operating Assets | 47,306 | 34,816 | 98,189 | -16,639 | 47,389 | -10,400 | Upgrade
|
Operating Cash Flow | 200,804 | 172,475 | 327,767 | 257,444 | 306,843 | 221,998 | Upgrade
|
Operating Cash Flow Growth | -15.27% | -47.38% | 27.32% | -16.10% | 38.22% | -14.16% | Upgrade
|
Capital Expenditures | -47,601 | -38,056 | -36,441 | -30,739 | -31,384 | -41,267 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | 441 | 6,831 | 6,924 | Upgrade
|
Cash Acquisitions | -24,923 | -784,974 | - | -670 | -14,916 | -320,764 | Upgrade
|
Sale (Purchase) of Intangibles | -27,549 | -33,438 | -51,888 | -21,428 | -46,057 | -36,621 | Upgrade
|
Investment in Securities | - | - | 12,624 | - | - | - | Upgrade
|
Other Investing Activities | -18,129 | 10,666 | -8,795 | -10,017 | 3,632 | 1,935 | Upgrade
|
Investing Cash Flow | -118,202 | -845,802 | -84,500 | -62,413 | -81,894 | -389,793 | Upgrade
|
Short-Term Debt Issued | - | 324,337 | - | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 472,275 | 50,000 | - | 80,000 | 326,000 | Upgrade
|
Total Debt Issued | 251,267 | 796,612 | 50,000 | - | 80,000 | 326,000 | Upgrade
|
Short-Term Debt Repaid | - | - | -15,000 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -25,379 | -50,000 | -60,000 | -206,000 | - | Upgrade
|
Total Debt Repaid | -211,355 | -25,379 | -65,000 | -60,000 | -206,000 | - | Upgrade
|
Net Debt Issued (Repaid) | 39,912 | 771,233 | -15,000 | -60,000 | -126,000 | 326,000 | Upgrade
|
Repurchase of Common Stock | -6,961 | -10,735 | -60,556 | -50,717 | -9,163 | -52,899 | Upgrade
|
Dividends Paid | -125,509 | -116,653 | -100,355 | -85,236 | -76,157 | -73,539 | Upgrade
|
Other Financing Activities | -29,797 | -29,785 | -19,712 | -20,345 | -18,159 | -18,507 | Upgrade
|
Financing Cash Flow | -122,355 | 614,060 | -195,623 | -216,298 | -229,479 | 181,055 | Upgrade
|
Foreign Exchange Rate Adjustments | -1,247 | 18,113 | 13,210 | 11,125 | 12,267 | -5,942 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | 1 | - | -1 | - | -1 | Upgrade
|
Net Cash Flow | -41,000 | -41,153 | 60,854 | -10,143 | 7,737 | 7,317 | Upgrade
|
Free Cash Flow | 153,203 | 134,419 | 291,326 | 226,705 | 275,459 | 180,731 | Upgrade
|
Free Cash Flow Growth | -21.15% | -53.86% | 28.50% | -17.70% | 52.41% | -22.58% | Upgrade
|
Free Cash Flow Margin | 8.65% | 8.38% | 19.18% | 17.49% | 22.05% | 13.89% | Upgrade
|
Free Cash Flow Per Share | 85.19 | 74.69 | 159.63 | 122.50 | 148.24 | 96.26 | Upgrade
|
Cash Income Tax Paid | 74,140 | 38,112 | 69,479 | 42,093 | 17,870 | 47,993 | Upgrade
|
Levered Free Cash Flow | 132,659 | 134,671 | 202,242 | 174,913 | 155,051 | 110,526 | Upgrade
|
Unlevered Free Cash Flow | 140,144 | 139,311 | 204,253 | 176,360 | 156,375 | 111,921 | Upgrade
|
Change in Net Working Capital | 86,856 | 24,914 | -42,061 | -12,502 | -4,331 | 43,764 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.